**Core Concept**
Bremelanotide is a melanocortin receptor agonist, specifically targeting the melanocortin 4 receptor (MC4R). This receptor plays a crucial role in the regulation of appetite, energy homeostasis, and sexual function.

**Why the Correct Answer is Right**
Bremelanotide works by activating the MC4R, which leads to increased sexual arousal, improved libido, and enhanced erectile function in both men and women. This drug has been specifically approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. The exact mechanism involves the activation of the MC4R, leading to the release of neurotransmitters such as dopamine and norepinephrine, which contribute to increased sexual desire.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Bremelanotide is not primarily used for the treatment of depression or anxiety disorders.
**Option B:** This option is incorrect because Bremelanotide is not a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI), and its primary indication is not for the treatment of depression or anxiety.
**Option C:** This option is incorrect because Bremelanotide is not used for the treatment of erectile dysfunction (ED) in men, although it can improve erectile function in some individuals.

**Clinical Pearl / High-Yield Fact**
Bremelanotide is the first FDA-approved medication for HSDD in premenopausal women, highlighting the importance of addressing female sexual dysfunction in clinical practice.

**Correct Answer:** D.